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Cobalt metallosis after revision metal-on-polyethylene total hip arthroplasty for catastrophic failure of
ceramic components is uncommon but a potentially devastating complication. Common ﬁndings asso-
ciated with heavy metal toxicity include cardiomyopathy, hypothyroidism, skin rashes, visual distur-
bances, hearing changes, polycythemia, weakness, fatigue, cognitive deterioration, and neuropathy. We
report a case of a 57-year-old woman who presented with complaints of progressively worsening hip
pain, fatigue, memory loss, lower extremity sensory loss, persistent tachycardia, and ocular changes 5
years after synovectomy and revision of a failed ceramic-on-ceramic total hip arthroplasty to metal-on-
polyethylene components. A cobalt level of 788.1 ppb and chromium level of 140 ppb were found on
presentation and subsequently decreased to 468.8 ppb and 105.9 ppb, respectively, 2 weeks after revi-
sion to a ceramic-on-polyethylene total hip arthroplasty. Improvement of symptoms accompanied this
decrease in cobalt and chromium levels. Revision of failed ceramic arthroplasties with later-generation
ceramics to avoid this potential complication is recommended.
Copyright © 2015 The Authors. Published by Elsevier Inc. on behalf of American Association of Hip and
Knee Surgeons. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).Introduction
Ceramic-on-ceramic total hip arthroplasties (THAs) were ﬁrst
developed in the 1970s, with the hope that the low linear wear rates
of ceramics would reduce revision rates [1,2] Unfortunately, ceramic
components can catastrophically fracture becauseof their brittleness
and steep Young's modulus curve [3]. The femoral head component
most often fails because of a traumatic event, in contrast to the
acetabular liner which often fails without history of trauma [4].
Recent data from the manufacturer, CeramTec GmbH, Plochin-
gen, Germany, have shown a signiﬁcant decrease in fracture rate of
the fourth-generation Biolox delta ceramic heads (0.002%)
compared to the third-generation ceramic heads (0.021%) [5]. The
fracture rates of the third- and fourth-generation ceramic liners
have remained relatively constant at 0.032% and 0.028%, respec-
tively [5]. When discussing revision component options afterd any potential or pertinent
conﬂict with this work. For
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es/by-nc-nd/4.0/).catastrophic failure, patients are often reluctant to accept another
ceramic device for fear of another component fracture. For this
reason among others, metal-on-polyethylene is often chosen in
conjunction with synovectomy to mitigate the residual ceramic
particles increasing wear rates. However, it has been demonstrated
that reliably removing all particulate ceramic debris without an
extensive dissection with anterior and posterior synovectomies is
extremely difﬁcult [6]. These residual particles embedded in the
polyethylene rapidly increase wear rates on the femoral head and
expose the patient to potential heavy metal toxicities.
We report a case of a 57-year-old woman with cobalt toxicity
after revision of a fractured ceramic-on-ceramic THA to ametal-on-
polyethylene THA. At the time of the initial revision surgery, the
ceramic head was found to be intact and the acetabular liner
fractured. The events leading to presentation at our hospital and
placing her in our care are described. Radiographic and intra-
operative ﬁndings are discussed. Finally, recommendations for
management and prevention of this complication are reviewed.Case history
Our patient is a 57-year-old woman referred to our ofﬁce with a
painful right hip and a diagnosis of cobalt toxicity. She underwent aan Association of Hip and Knee Surgeons. This is an open access article under the CC
Figure 2. Prerevision T1 coronal pelvis magnetic resonance imaging demonstrating
extensive foreign body reaction.
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to metal-on-polyethylene components 3 years later for mechanical
failure. She had been doing well until 1 year before presentation to
our ofﬁce in early 2015, when she began experiencing right hip
pain. Other ailments included worsening fatigue, memory loss,
lower extremity sensory loss, new onset tachycardia, hypothy-
roidism, and vision changes. On examination, she had painwith leg
raise and decreased sensation to the dorsum of her foot. Laboratory
values were signiﬁcant for a chromium level of 140 ppb (normal,
1.8 ppb) and a cobalt level of 788.1 ppb (normal, 3.6 ppb). Plain
radiographs revealed an obviously aspherical head component of
her right THA, as well as multiple radiographically hyperdense loci
surrounding her implant and in her thigh (Fig. 1a and b). Magnetic
resonance imaging revealed extensive foreign body reaction sur-
rounding the right THA (Fig. 2).
We performed a revision right THA with a 32-mm ceramic
head on a polyethylene liner (Fig. 3a and b). On entering the
relatively thin, attenuated pseudocapsule, a large amount of black
ﬂuid was encountered; ﬂuid and tissue samples were sent for
culture and Gram stain. Ultimately, cultures demonstrated no
growth. The surrounding tissues and pseudocapsule were of poor
quality with obvious black staining and areas of osteolysis pos-
terior and superolaterally around the acetabular component. The
bone otherwise appeared healthy and viable. The acetabular
component was easily removed owing to the surrounding
osteolysis with only one area of bony ingrowth measuring <1
cm  1 cm. The shell was revised from a 52-mm shell to a Depuy
Pinnacle revision 58-mm titanium shell (Depuy, Warsaw IN) with
a 10-degree-elevated rim liner and placement of 5 titanium
screws. The titanium Stryker secure-ﬁt femoral component
(Stryker, Kalamazoo MI) was well ﬁxed and retained, but the
femoral head was profoundly misshapen and removed (Fig. 4).
The trunnion showed minor corrosion, and a CeramTec 32-mm
ceramic head (CeramTec, Plochingen Germany) with a titanium
revision sleeve was placed. After thorough debridement and
betadine lavage, the wound was primarily closed [7].
Postoperatively, neurology, ophthalmology, and cardiology were
consulted for management of new onset sinus tachycardia, visual
changes, and distal lower extremity neuropathy with no acute
intervention. She was discharged on postoperative day 3 without
incident. Over the course of the following 4 months, the patient's
symptoms steadily improved with cobalt levels of 468.8, 282.2, and
180.0 ppb at 2 weeks, 2 months, and 3 months, respectively. At her
most recent follow-upvisit, shehasminimalpainwith righthip range
of motion and is able to ambulate comfortably. The sinus tachycardiaFigure 1. (a) Prerevision anteroposterior radiograph pelvis and (b) lateresolved, although she reports occasional palpitationswhile sleeping
and continues to smoke 1 pack of cigarettes per day. The cardio-
reactive protein level has decreased from 19.16 (normal: 0-10mg/L)
on initial presentation to 1.69 mg/L at 8 months postoperatively. The
levothyroxine requirement for hypothyroidism remained constant at
25 mcg daily, whereas the thyroid-stimulating hormone level has
steadily declined from 2.510 (0.350-5.500 uIU/mL) 1 month after
surgery to 1.845 and 1.160 uIU/mL at 7 and 8months postoperatively.
Visual acuity and lower extremity neuropathy continue to slowly
improve, and overall, she is content with her recovery and progress.Discussion
Our patient presented with the most common symptoms
associated with cobalt toxicity. From prior reports of metallosis,
symptoms of toxicity present within 2 years after revision surgery
to metal-on-polyethylene components from failed ceramic-on-
ceramic components [8-12]. However, our patient presented 8
years after revision with memory, sensory, ocular, and cardiac
symptoms of roughly 1-year duration due to heavy metal toxicity,
well outside the normal temporal onset of heavy metal toxicity.ral view showing misshapen head, “debris cloud,“ and osteolysis.
Figure 3. (a) Postrevision anteroposterior pelvis radiograph and (b) lateral view showing a well-placed 58-mm Depuy Pinnacle revision cup with 5 screws and 32-mm ceramic head.
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fractured ceramic total hip replacement with metallic components
can result in metallosis. Several authors have reported symptom-
atic cobalt toxicity after revision of a failed ceramic head compo-
nent to a metal-on-polyethylene articulation, but there is a paucity
of literature describing the failure of ceramic acetabular compo-
nents [8,10-12]. These reports showed whole blood serum cobalt
levels ranged from 398 to 6521 ppb, with one case resulting in fatal
cardiomyopathy [8]. Our patient presented with a cobalt level of
788.1 ppb. In each case, a thick black ﬂuid was encountered on
entering the capsule, and an obviously misshapen metal femoral
head was retrieved. Further analysis of the components showed
ceramic material embedded in the polyethylene and surrounding
tissues, which resulted in third-body wear on the femoral head.
Reports of cobalt toxicity from failed metal-on-metal THAs have
reported whole blood levels in the range of 15-83 ppb, signiﬁcantly
less compared to third-body wear from revision failed ceramic
components [13-15]. This is likely related to both the volume and
mechanism of how the metal particles are generated.
Given the multiple reports of cobalt toxicity after revision for
failed ceramic components, it is recommended that revisions
should consist of a harder material or a newer-generation ceramic
replacement. Removal of all ceramic particles during revision re-
quires extensive dissection including posterior and anterior syno-
vectomies with no guarantee of complete success [6]. Avoiding this
unnecessarily morbid dissection and addressing any malposition-
ing at the time of revision mitigates the potential for theFigure 4. Photograph of a retrieved, misshapen, 28-mm, cobalt-chrome, modular
femoral head (left) next to an unused head of the same size (right).complication of metallosis. If a metal head was implanted at the
time of revision, careful clinical follow-up and monitoring of cobalt
blood levels are warranted.
Summary
Failure of THA ceramic components, although less common since
recent advances in manufacturing, is a difﬁcult problem to address
but must be approached appropriately [5]. Revision metal compo-
nents create the potential for metallosis given the inability to reliably
eliminate third-body wear by removing all ceramic fragments.
Revision THA must consist of extensive debridement with incorpo-
ration of later-generation ceramic components and placement of a
titanium revision sleeve if a previously used taper is retained to
prevent the debilitating complication of heavy metal toxicity.
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